A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia

Biological Psychiatry

Volumn 45, Issue 4, 1999, Pages 512-514

  Goff, Donald C ^a   Henderson, David C ^a   Evins, A Eden ^a   Amico, Edward ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Clozapine; D cycloserine; Glutamate; Glycine; Negative symptoms; Schizophrenia

Indexed keywords

CLOZAPINE; CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MENTAL DISEASE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; CLOZAPINE; CROSS-OVER STUDIES; CYCLOSERINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID AGONISTS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0033557737     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00367-9     Document Type: Article

References (17)

1. Arvanov V., Liang X., Schwartz J., et al. Clozapine and haloperidol modulate N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther. 283:1997;226-234.
2. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1997;787-794.
3. Banerjee S.P., Zuck L.G., Yablonsky-Alter E., Lidsky T.I. Glutamate agonist activity Implications for antipsychotic drug action and schizophrenia . Neuroreport. 6:1995;2500-2504.
4. Corbett R., Camacho R., Woods A.T., et al. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology. 120:1995;67-74.
5. Emmett M., Mick S., Cler J. Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology. 30:1991;1167-1171.
6. Evins A., Amico E., Shih V., Goff D. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. J Neural Transm. 104:1997;761-766.
7. Fitzgerald L.W., Deutch A.Y., Gasic G., Heinemann S.F., Nestler E.J. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci. 15:1995;2453-2461.
8. Fletcher E.J., MacDonald J.F. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur J Pharmacol. 235:1993;291-295.
9. Goff D., Tsai G., Levitt J., et al. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999 56:1999;21-27.
10. Goff D.C., Tsai G., Manoach D.S., Coyle J.T. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry. 152:1995;1213-1215.
11. Goff D.C., Tsai G., Manoach D.S., Flood J., Darby D.G., Coyle J.T. D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry. 153:1996;1628-1630.
12. Goff D., Wine L. Glutamate in schizophrenia Clinical and research implications . Schizophr Res. 27:1997;157-168.
13. Heresco-Levy U., Silipo G., Javitt D.C. Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia. Psychopharmacol Bull. 32:1996;731-740.
14. Krystal J.H., Karper L.P., Seibyl J.P., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses . Arch Gen Psychiatry. 51:1994;199-214.
15. McCoy L., Richfield E.K. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain. Neurosci Lett. 213:1996;137-141.
16. Schneider J., Wade T., Lidsky T. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. Neuroreport. 9:1998;133-136.
17. Yamamoto B.K., Cooperman M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci. 14:1994;4159-4166.